PDTM-05. CD271 (p75NTR) AS A NOVEL DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR SHH MEDULLOBLASTOMA

The extensive heterogeneity within the medulloblastoma (MB) molecular variants has revealed a critical need for subtype-specific biomarkers and therapeutic strategies. Using a high throughput flow cytometry screen and gain/loss of function studies, we previously identified CD271/p75NTR as a candidat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Liang, Lisa, Morrison, Ludivine, Tatari, Nazanin, Ramaswamy, Vijay, Bigio, Marc Del, Taylor, Michael, Hawkins, Cynthia, Chan, Jennifer A, Werbowetski-Ogilvie, Tamra
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692373/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.770
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires